Peptide Stacks: What 'Stacking' Means in Research Context
Stacking is taking two or more peptides together on the theory that they work better combined. One combination has human evidence for that. The rest are untested pairs of compounds that are mostly untested on their own.
Human studies show GHRH + ghrelin-type peptides release more growth hormone together than apart. No other commonly discussed stack has been tested as a combination in humans or animals.
- Covers
- GHRH + GHRP synergy (human, single-dose), healing stacks (untested), nootropic stacks (untested), GLP-1 + growth hormone peptides (untested)
What stacking is
“Stacking” is bodybuilding slang for taking several compounds at once. Applied to peptides, it means injecting two or more together, usually on the theory that they work through different mechanisms and the effects add up, or better, multiply.
Sometimes that is true and tested. Usually it is a plausible story. This guide goes through the stacks people actually talk about and says, for each, whether anyone has checked.
Why people stack
Three arguments come up. The mechanism argument: two peptides act on different pathways toward the same goal, so together they should do more. The hormone argument: raise growth hormone with one peptide, and the others will work better in a more anabolic body. The anecdote argument: people on forums report better results on stacks.
The first is testable and has been tested exactly once in this space. The second is a hypothesis. The third is the survivorship bias problem described in how peptides are studied: the people whose stacks worked post about them.
The evidence gap
Real drug combinations get studied. Cancer and HIV treatment are built on trials of combinations, using methods that measure whether two drugs together beat the sum of their parts (Chou, 2010). No such study exists for any research-peptide stack. Most of the peptides in these stacks have no human trial on their own, so the combination sits on top of nothing. “No research” here does not mean “the research was negative.” It means the question has never been asked.
The common stacks, assessed
CJC-1295 + ipamorelin (the growth hormone stack)
The one with evidence. GHRH-type peptides (CJC-1295, sermorelin) tell the pituitary to release growth hormone; ghrelin-type peptides (ipamorelin, GHRP-2) do the same through a different receptor and also lift the brake that normally limits the response. Given together in humans, the growth hormone pulse is much larger than either alone, more than additive (Bowers, 1996). That is proven for the hormone pulse, over hours. Whether a bigger pulse three times a day builds more muscle or health over months has not been tested for the stack or for either peptide alone.
BPC-157 + TB-500 (the healing stack)
The most popular combination and the least tested. BPC-157 and TB-500 each have animal data for healing through different mechanisms, which is the whole argument for pairing them. No study has given both to the same animal, let alone a person. Neither has a human trial alone. If you take both and heal, nobody, including you, can say which one did it.
CJC-1295 + ipamorelin + BPC-157 + TB-500 (the kitchen sink)
Four compounds, one of which pairs have any combination data. Adding compounds adds unknowns faster than it adds evidence, and it makes side effects impossible to attribute.
Selank + Semax (the nootropic stack)
Selank for anxiety, Semax for focus, both Russian nasal sprays with small Russian trials each. No study of the two together. The logic is reasonable; the evidence is absent.
Growth hormone peptides + semaglutide (the recomposition stack)
The idea is to lose fat on semaglutide while a growth hormone peptide protects muscle, since a quarter to a third of GLP-1 weight loss is lean mass (Wilding et al., 2021). Nobody has tested it. Growth hormone raises blood sugar and semaglutide lowers it, so the interaction is not trivial, and anyone doing this is running an experiment on themselves with a prescription drug.
What synergy would actually require
For a combination to be called synergistic, someone has to measure each compound alone, then together, at matched doses, and show the combination does more than the sum. That has been done for GHRH and ghrelin-type peptides on growth hormone release. It has not been done for anything else on this page. Until it is, “synergy” is a marketing word.
If you combine anyway
Not advice, just what makes the experiment interpretable. Start one compound at a time, so you know what each does to you. Change one thing per cycle. Keep a log. Get bloodwork before and during, especially blood sugar and IGF-1 if growth hormone peptides are involved. Buy from a source that publishes third-party tests, because a stack from a bad vendor is several unknowns in one syringe. See the safety guide.
Frequently Asked Questions
Is CJC-1295 + ipamorelin proven?
The bigger growth hormone pulse is proven in humans. Muscle, fat, or recovery outcomes from the stack are not.
Does BPC-157 + TB-500 work better than either alone?
Unknown. The pair has never been studied, together or, in humans, apart.
Can peptides be mixed in one syringe?
Users combine growth hormone peptides in one syringe routinely and report no problem. No stability study exists for most pairs. Mixing a research peptide with a prescription drug like semaglutide is a different matter; do not.
Why does nobody study stacks?
The same reason nobody studies most single research peptides: no patent, no company, no funding. See why most peptide evidence is preclinical.
References
- Bowers CY. (1996). On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinol Metab Clin North Am. PubMed
- Chou TC. (2010). Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. PubMed
- Wilding JPH, et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. PubMed
- Fosgerau K, Hoffmann T. (2015). Peptide therapeutics: current status and future directions. Drug Discov Today. PubMed